Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2013, Vol.260 (1), p.327-329
Hauptverfasser:	Ghezzi, A., Rocca, M. A., Baroncini, D., Annovazzi, P., Zaffaroni, M., Minonzio, G., Comi, G., Filippi, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Disability Evaluation Female Fingolimod Hydrochloride Humans Immunosuppressive Agents - administration & dosage Letter to the Editors Magnetic Resonance Imaging Medicine Medicine & Public Health Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Neurology Neuroradiology Neurosciences Propylene Glycols - administration & dosage Recurrence Sphingosine - administration & dosage Sphingosine - analogs & derivatives Substance Withdrawal Syndrome - drug therapy Substance Withdrawal Syndrome - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!